Epidemiology of Young Lung Cancer - Survey

NSCLC Clinical Trial

— EoYLC  

Official title:

This is a 100% Virtual (Remote) Study (Survey, and Voluntary Blood Donation) to Explore Potential Environmental, Lifestyle and Genetic Factors That May be Associated With Driver Mutations of Young Lung Cancer in the USA.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04640259
• Other study ID #: ALCMI-004
• Status: Recruiting
• Start date: February 1, 2021
• Est. completion date: December 30, 2026

Study information

• Verified date: February 2024
• Source: Addario Lung Cancer Medical Institute
• Contact: Richard Erwin
• Phone: 888-443-6952
• Email: rerwin[@]alcmi.net
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: December 30, 2026
• Est. primary completion date: December 30, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Male or female aged 18 years and over; or the age of majority for their residential state at the time of enrollment

2. Documentation of primary NSCLC, any stage

3. Less than 50 years of age at the time of NSCLC diagnosis

4. Documentation of testing by a CLIA certified lab for genomic drivers of lung cancer

5. Willingness to undergo all study procedure

6. Provision of written informed consent

Exclusion Criteria:

1. Male or female aged less than 18 years; or less than the age of majority for their residential state

2. Greater than or equal to 50 years of age at the time of NSCLC diagnosis

3. No documentation of mutation testing

4. Unwilling to undergo all study procedures

5. Unable or unwilling to provide consent

Related Conditions & MeSH terms

• NSCLC

Intervention

Other:
• Online Survey
Epidemiological Survey (approx 200 questions)

Locations

Country	Name	City	State
United States	USC Keck School of Medicine	Los Angeles	California
United States	Addario Lung Cancer Medical Institute	San Carlos	California

Sponsors (3)

Lead Sponsor	Collaborator
Addario Lung Cancer Medical Institute	Ohio State University Comprehensive Cancer Center, University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exploratory epidemiology correlates	Exploratory correlations between all questionnaire variables (demographic factors, medical history, smoking history, early life exposures (child and mother), residential history, occupational history, menstrual and reproductive history, diet, and physical activity.	1 month